NCT04170426View on ClinicalTrials.gov

Autologous Adipose-derived Stem Cells (AdMSCs) for Rheumatoid Arthritis

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

December 31, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2026

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

autologous adipose derived stem cells

Culture expanded mesenchymal stem cells isolated from patient's own abdominal fat tissue

Sponsors
All Listed Sponsors
lead

Celltex Therapeutics Corporation

INDUSTRY